EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

Adverse events associated with the use of cannabis-based products in people living with cancer: a systematic scoping review

Irene Cheah, Jennifer Hunter, Ingrid Gelissen, Wai-Jo Jocelin Chan, Joanna E Harnett

Supportive Care in Cancer · 2025

DOI: 10.1007/s00520-024-09087-w ↗

Kurz gefasst

Scoping Review in der Zeitschrift Supportive Care in Cancer, 2025. Verfasst von Irene Cheah und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, Australia. iche6980@uni.sydney.edu.au. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Sydney.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To summarise the extent and type of evidence in relation to adverse events (AEs) associated with the use of cannabis-based products (CBP) in people living with cancer.

Methods

The Joanna Briggs Institute (JBI) methodology for scoping reviews was applied. A search was performed in MEDLINE (Ovid), Embase (Ovid), CINAHL (EBSCOhost), Scopus, Web of Science Core Collections and AMED (Ovid) from their inception to 7 May 2023. Primary studies reporting AEs associated with any form of natural or synthetic CBP use in any cancer care setting and location were included.

Results

One hundred fifty-two studies were included, with the most prevalent being randomised controlled trials (RCTs) ( n = 61), followed by non-randomised controlled trials ( n = 26) and case reports ( n = 23). CBP was mainly used in gastrointestinal, liver, or peritoneal cancer ( n = 98) and haematological or lymphoid cancer ( n = 92), primarily to manage nausea and vomiting ( n = 78) and cancer pain ( n = 37). The most common CBP ingredients were combinations of THC and CBD ( n = 69), synthetic THC ( n = 47), single compounds of THC ( n = 42) and CBD ( n = 16) with diverse forms, administration routes and doses. The primary methods of administration were oral ( n = 94) and inhalation ( n = 54). A broad range of AEs were reported; the most common were related to the nervous system ( n = 118), psychiatric ( n = 101) and gastrointestinal system ( n = 81). Diverse patient characteristics, significant under-reporting and low-quality reporting were observed in many studies.

Conclusions

More rigorous research designs that prioritise comprehensive, standardised reporting of AEs and CBP use are required to fully elucidate the safety profile of CBP use in cancer care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansMedical MarijuanaCancer PainNauseaVomitingRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Adverse eventsCannabisRandomised controlled trial

Substanzen

Medical Marijuana

Autor:innen und Institutionen

  • School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, Australia. iche6980@uni.sydney.edu.au.
  • School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
  • Health Research Group, Sydney, Australia.
  • School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, Australia. joanna.harnett@sydney.edu.au.

Förderung

  • University of Sydney

Zitieren

APA

Cheah, I., Hunter, J., Gelissen, I., Chan, W. J., & Harnett, J. E. (2025). Adverse events associated with the use of cannabis-based products in people living with cancer: a systematic scoping review. Supportive Care in Cancer. https://doi.org/10.1007/s00520-024-09087-w

Vancouver

Cheah I, Hunter J, Gelissen I, Chan WJ, Harnett JE. Adverse events associated with the use of cannabis-based products in people living with cancer: a systematic scoping review. Supportive Care in Cancer. 2025. doi:10.1007/s00520-024-09087-w

BibTeX
@article{Cheah2025,
  author = {Cheah, Irene and Hunter, Jennifer and Gelissen, Ingrid and Chan, Wai-Jo Jocelin and Harnett, Joanna E},
  title = {Adverse events associated with the use of cannabis-based products in people living with cancer: a systematic scoping review},
  journal = {Supportive Care in Cancer},
  year = {2025},
  doi = {10.1007/s00520-024-09087-w}
}
Kostenlos starten →